The AIM Medical Oncology Solution is an oncology benefits management program that promotes evidence-based cancer care. Equipped with value-based reimbursement strategies and AIM Cancer Treatment Pathways, the solution helps your providers deliver affordable care with high efficacy and low toxicity.
Simplify the path to cost-effective, evidence-based cancer care
Merged seamlessly into provider workflows through the AIM ProviderPortalSM or EMR integration, our automated clinical review process simplifies your providers' delivery of evidence-based care. It can identify the most appropriate care for your members or direct your providers to a peer-to-peer conversation with our physicians.
Clinicians are available for cases that do not meet clinical criteria
Multiply your expertise. Showcase your credibility.
An experienced team of physicians and nurses lead and support our Medical Oncology Solution. Their expertise across numerous clinical specialties expands your organization's clinical brainpower and acumen immediately. It also reinforces your clinical credibility and accelerates acceptance among your providers.
Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO
Medical Director, Medical Oncology Programs and Genetics
Michael Fisch, MD, serves as Medical Director of Medical Oncology Programs and Genetics for AIM. In his role, he works closely with the executive leadership team to provide clinical expertise for the expansion of the AIM Medical Oncology Solution and for the AIM Genetic Testing Solution.
Stacey Ban, MD, serves as the clinical lead for the AIM Medical Oncology and Specialty Drugs Solutions. In her role, she works closely with the executive leadership team to provide front line clinical expertise for the expansion of our integrated Oncology Solution including development of clinical pathways. Since joining AIM, she implemented solutions for Specialty Drugs and Radiation Therapy.